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Edited by Gianni CesareniAbstract Recently, much attention has been given to chitosan
and its hydrolyzed products due to their diverse biological activ-
ities. For the ﬁrst time here we report the inhibitory eﬀect of chi-
tooligosaccharides (COS) on activation and expression of matrix
metalloproteinase-2 (MMP-2) in primary human dermal ﬁbro-
blasts (HDFs). COS with 3–5 kDa exhibited the highest inhibi-
tory eﬀect on MMP-2 activity in HDFs assessed by gelatin
zymography. Interestingly, protein expression of MMP-2 was
also inhibited by COS with same molecular weight. This inhibi-
tion was caused by the decrease of the gene expression and tran-
scriptional activity of MMP-2. Furthermore, it was found that
COS repressed the gene expression of c-fos, a part of AP-1 tran-
scription factor. These results suggest that COS may play an
important role in the prevention and treatment of MMP-2 med-
iated several health problems such as metastasis and wrinkle
formation.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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reporter assay1. Introduction
Matrix metalloproteinases (MMPs) are a family of secreted
or transmembrane zinc-endopeptidases [1] that are capable of
digesting extracellular matrix (ECM), such as ﬁbrillar and non-
ﬁbrillar collagens, ﬁbronectin, laminin, elastin and basement
membrane glycoproteins under physiological conditions [2].
MMPs play an important role not only in physiologic degrada-
tion of ECM mediating tissue morohogenesis, tissue repair,
and angiogenesis but also in pathologic conditions character-
ized by excessive degradation of ECM such as chronic inﬂam-
mation, wrinkle formation, arthritis, osteoporosis, periodontal
disease, tumor invasion and metastasis. Direct evidence for the
involvement of distinct MMPs in tumor growth and invasion
has been revealed by studies with either MMP-2 knockoutAbbreviations: MMP-2, matrix metalloproteinase-2; COS, chitooligo-
saccharides; ECM, extracellular matrix; HDFs, human dermal ﬁbro-
blasts; PMA, phorbol 12-myristate 13-acetate
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genesis [3]. Therefore, inhibition of MMP activities in the
extracellular space has been extensively studied as an approach
to inhibit metastasis and wrinkle formation. At present, several
MMP inhibitors are under clinical trials and most of these
MMP inhibitors are synthetic peptides, chemically modiﬁed
tetracyclines, bisphosphonates or compounds isolated from
natural sources. However, most of these drugs are reported
to exert side eﬀects such as, musculoskeletal pain in tendons
and joints [4]. Therefore, we have made an eﬀort to screen safe
and eﬀective MMP inhibitors and found for the ﬁrst time that
chitooligosaccharides (COS) can inhibit MMP-2 activation
and expression. Chitosan, a non-toxic biopolymer, is a par-
tially deacetylated polymer of N-acetyl glucosamine, which is
obtained after alkaline deacetylation of the chitin derived from
the exoskeletons of crustaceans and arthropods. It has received
considerable attention for its commercial applications in bio-
medical and chemical ﬁelds because of its biological functions
such as antitumor activity [5], antimicrobial activity [6], anti-
mutagenic activity [7] and immuno-enhancing eﬀects [8].
COS, partially hydrolyzed products of chitosan are of great
interest in pharmaceutical and medicinal applications due to
high solubility and nontoxicity. However, little information
on the inhibitory eﬀect of COS on MMP expression is avail-
able until now. Therefore, in the present work we carried out
a detailed study to investigate the inhibitory eﬀects of COS
on MMP-2 expression in normal human cells.2. Materials and methods
2.1. Materials
Chitosan (degree of deacetylation, 93%; average molecular weight,
280 kDa; viscosity, 13 cP) prepared from crab shell chitin was donated
by Kitto Life Co. (Seoul, Korea). Chitosanase from Bacillus sp.
(35000 U/g of protein) was purchased from Amicogen Co. (Jinju, Kor-
ea). Ultraﬁltration membrane (UF) reactor system (Minitan) and
membranes, for the fractionations of COS were purchased from
Millipore Co. (Bedford, MA, USA). Dulbecco’s modiﬁed Eagle’s med-
ium (DMEM), trypsin–EDTA, penicillin/streptomycin/amphotericin
(10000 U/ml, 10000 lg/ml, and 2500 lg/ml, respectively) and fetal bo-
vine serum (FBS) were obtained from Gibco BRL, Life Technologies
(NY, USA). Human dermal ﬁbroblasts were kindly donated by LG
HG&CM Research Institute (Daejeon, Korea). MTT reagent, gelatin,
agarose, PMA (phorbol 12-myristate 13-acetate) and other materials
were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
2.2. Preparation of COS using UF membrane bioreactor
Chitosan solution (1%) was prepared by dispersing 100 g of chitosan
in 1.0 L of distilled water while stirring with 550 ml of 1.0 M lactic acid
and making the ﬁnal volume up to 10 L with distilled water. The pH ofblished by Elsevier B.V. All rights reserved.
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COS were prepared by continuous hydrolysis of chitosan according
to our previous method, in an UF membrane reactor system connected
to an immobilized enzyme column reactor in which chitosanase (from
Bacillus sp., Amicogen Co.) was immobilized [9]. Four UF membranes
with diﬀerent molecular weight cut-oﬀs (MWCO of 10, 5, 3, and
1 kDa) were used to separate COS into ﬁve diﬀerent molecular weight
fractionations. Fractionated COS were separately dialyzed using 10, 5,
3, and 1 kDa molecular weight cut-oﬀ dialysis membranes (Pierce Bio-
technology Inc, Rockfod, IL, USA) and lyophilized.
2.3. Cell culture
Cell lines were separately grown as monolayers at 5% CO2 and 37 C
humidiﬁed atmosphere using appropriate media supplemented with
10% fetal bovine serum, 2 mM glutamine and 100 lg/ml penicillin–
streptomycin. DMEM was used as the culture medium for human der-
mal ﬁbroblasts (HDFs) cultured primarily from human fetal skin. Cells
were passaged 3 times a week by treating with trypsin–EDTA and used
for experiments after 5 passages.
2.4. MTT assay
Cytotoxic levels of COS on HDFs were measured using MTT
(3-(4,5-dimethyl-2-yl)-2,5-diphenyltetrazolium bromide) method as
described by Hansen et al. [10].
2.5. Gelatin zymography
Expression and activation of MMP-2 were determined by zymogra-
phy as described previously [11] in the presence or absence of COS.
Conditioned medium containing same amount of total proteins was
loaded into each well of polyacrylamide gels containing 1.5 mg/ml gel-
atin and electrophoresed under non-reducing conditions. Depending
on the purpose, diﬀerent protein amounts for each experiment were
used for gelatin zymography analysis. Gelatinolytic bands were ob-
served as clear zones against the blue background and the intensity
of the bands was estimated using ImageMaster Software (Amersham
Pharmacia Bioscience, NJ, USA). Chitooligosaccharides with 3-5 kDa (μg/ml)  
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Fig. 1. Eﬀect of COS with diﬀerent molecular weights on viability of HDFs
diﬀerent molecular weights (A, <1 kDa; B, 1–3 kDa; C, 3–5 kDa; D, 5–10 kD
given as means of values ± S.D. from three independent experiments.2.6. Western blot analysis
Western blotting was performed according to standard procedures.
Brieﬂy, HDFs were lysed in lysis buﬀer containing 50 mM Tris–HCl,
pH 7.5, 0.4% Nonidet P-40, 120 mM NaCl, 1.5 mM MgCl2, 2 mM
phenylmethylsulfonyl ﬂuoride, 80 lg/ml leupeptin, 3 mM NaF and 1
mM DTT at 4 C for 30 min. Cell lysates (10 lg) were resolved on a
4–20% Novex gradient gel (Invitrogen, USA), electrotransferred onto
a nitrocellulose membrane, and blocked with 10% skim milk. Proform
of anti-MMP-2 primary monoclonal antibodies (Cat. No. MAB13405,
Chemicon, CA, USA) were used to detect pro-MMP-2 protein using
chemiluminescent ECL assay kit (Amersham Pharmacia Biosciences,
NJ, USA) according to the manufacturer’s instructions. Western blot
bands were quantiﬁed using ImageMaster software (Amersham Phar-
macia Biosciences, NJ, USA).
2.7. Transfection and reporter gene assay
Human dermal ﬁbroblasts were seeded in 6-well plates and incu-
bated at 37 C. At about 70–80% of conﬂuency, cells were washed with
DMEM and incubated with DMEM without serum and antibiotics for
5 h. Then the cells were transfected with DNA mixture containing 1 lg
of MMP-2 promoter containing pGL3 reporter vector and 300 ng of
pcDNA 3.1 which adjusts a total amount of DNA per well by Lipo-
fectamine reagent (Invitrogen, USA) as instructed by the manufac-
turer. After 72 h of incubation, cells were lysed and luciferase
activity was measured using a luminometer (Tecan Austria GmbH,
Austria). The luciferase activity was normalized to transfection eﬃ-
ciency, monitored by b-galactosidase activity using o-nitrophenyl b-
galactopyranoside as a substrate. Data were expressed as means ± S.E.
of the mean (n = 3). Values were analyzed statistically relative to the
control using Student’s t-test.
2.8. RT-PCR
For RT-PCR, 1 lg of total RNA prepared from HDFs was reverse-
transcribed to generate ﬁrst strand cDNA using AMV reverse trans-
criptase, (USB coporation, OH, USA). Synthesized cDNA was used
as a template in PCR using Taq polymerase, (USB corporation, OH,Chitooligosaccharides with 5-10 kDa (μg/ml) 
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in the presence or absence of FBS. Cells were treated with COS with
a) and cell viability was determined by MTT assay after 24 h. Data are
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GTGCTGAAGGACACACTAAAGAAGA-3 0, reverse primer: 5 0-
TTGCCATCCTTCTCAAAGTTGTAGG-3 0), c-fos (forward primer:
5 0-CTACGAGGCGTCATCCTCCCG-3 0, reverse primer: 5 0-
AGCTCCCTCCTCCGGTTGCGGCAT-3 0) and glyceraldehyde-3-
phosphate dehydrogenase (G3PDH) (forward primer: 5 0-TGAAG
GTCGGTGTGAACGGATTTGGC-3 0, reverse primer: 5 0-CAT-
GTAGGCCATGAGGTCCACCAC-30). PCR products were then
separated on a 2% agarose gel and visualized by ethidium bromide
staining.
2.9. Statistical analysis
Comparisons of all data were performed using two-tailed, unpaired
Student’s t-test. A P value less than 0.05 was considered statistically
signiﬁcant. Data are expressed as means ± S.E.Fig. 2. Eﬀect of COS with diﬀerent molecular weights on activity of
MMP-2 in HDFs with treatment concentration. HDFs stimulated with
100 ng/ml of PMA to induce MMP expression were treated with COS
with diﬀerent molecular weights at 50, 100 and 500 lg/ml under serum-
free conditions for 7 days. Upper panel illustrates MMP-2 activity in
conditioned media as determined by gelatin zymography. Lower panel
represents respective relative MMP-2 activity of each treatment
calculated considering 100% activity in PMA treated group. Data are
given as means of values ± S.D. from three independent experiments.3. Results
3.1. Eﬀect of COS with diﬀerent molecular weights on
proliferation of HDFs
The purpose of present study was to investigate the inhibi-
tory eﬀects of COS with diﬀerent molecular weights on
MMP-2 expression and activation. Therefore, in the ﬁrst place,
non-cytotoxic concentrations of COS on normal HDFs in the
presence or absence of FBS were determined by performing
MTT assay for MMP inhibition studies. Interestingly, as
shown in Fig. 1, all COS used in this study did not exert any
cytotoxic eﬀect on HDFs even at the highest tested concentra-
tion (1000 lg/ml) in the presence or absence of FBS.
3.2. Concentration and time dependent inhibitory eﬀects of COS
with diﬀerent molecular weights on MMP-2
Based on the above results, further studies were carried out
to examine the inhibitory eﬀect of COS with diﬀerent molecu-
lar weights on MMP-2 activation and expression in HDFs.
Conditioned medium of HDFs treated with COS with diﬀerent
molecular weights was used for gelatin zymography. It was ob-
served clearly that latent form of MMP-2 (proMMP-2) was
converted into its active form by PMA treatment (Fig. 2).
All COS above 50 lg/ml exhibited a marked inhibitory eﬀect
on MMP-2 activation in HDFs compared with PMA treat-
ment groups. To clarify the inhibitory eﬀect of COS onFig. 3. Eﬀect of COS with diﬀerent molecular weights on activity of MMP-
PMA to induce MMP expression were treated with COS with diﬀerent molecu
activity in conditioned media was determined by gelatin zymography as descr
the following equation. Relative MMP-2 activity (%) = (intensity of a ban
considered as an independent group. Data are given as means of values ± S.MMP-2, time dependent inhibitory eﬀect was investigated.
As shown in Fig. 3, treatment with PMA enhanced
proMMP-2 activity signiﬁcantly compared with blank group
(P < 0.01). Moreover, proMMP-2 activity was clearly in-
creased with incubation time in both PMA and COS treatment
groups below 1 kDa. However, inhibitory eﬀect of COS above2 in HDFs with incubation time. HDFs stimulated with 100 ng/ml of
lar weights under serum-free conditions for 1, 3, 5 and 7 days. MMP-2
ibed in the text. Values are expressed as relative MMP-2 activities using
d/total intensity of bands obtained for a day) · 100. Each day was
D. from three independent experiments.
Fig. 4. Western blot analysis of protein expression of proMMP-2 in
HDFs after treatment with diﬀerent molecular weights of COS.
Western blot analysis of cell lysates was performed using proform of
MMP-2 monoclonal antibodies as indicated. Lower panel represents
respective relative protein expression as percentage. Values are
expressed as relative protein expression using the following equation.
Relative protein expression (%) = (intensity of a band/total intensity of
bands) · 100. Expression of b-actin protein was used as the control for
normalization of proMMP-2 protein.
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incubation time (P < 0.01). Furthermore, among all molecular
weight fractions of COS, 3–5 kDa fraction exerted the highest
inhibitory eﬀect on proMMP-2 activity.
3.3. Inhibitory eﬀects of COS with diﬀerent molecular weights on
proMMP-2 protein expression in HDFs
To determine the inhibitory eﬀect of COS with diﬀerent
molecular weights on the protein expression level of
proMMP-2, Western blot analysis was performed in HDFs.
As shown in Fig. 4, PMA treatment signiﬁcantly increased
the expression level of proMMP-2 compared with blank
group. The expression level of proMMP-2 protein was de-
creased with the treatment of COS with all molecular weights,
compared with PMA treatment group. However, the highest
inhibition was observed with 3–5 kDa of COS, and that inhibi-
tion was signiﬁcantly diﬀerent (P < 0.01) from those of the
other molecular weights.
3.4. Transcriptional activation of MMP-2 in HDFs is inhibited
by COS
Furthermore, it was examined whether transcriptional
activity of MMP-2 is aﬀected by COS with diﬀerent molecu-
lar weights using a reporter construct including MMP-2-
luciferase gene. As shown in Fig. 5, transcriptional activity
of MMP-2 gene was increased signiﬁcantly (P < 0.01) in con-
trol group treated with PMA, compared to the untreated
blank group. However, the transcriptional activity of
MMP-2 gene induced by PMA was considerably repressed
by treatment with COS. Especially, COS with 3–5 kDa
exhibited the highest inhibitory eﬀect on transcriptional
activity of MMP-2 gene. The inhibitory eﬀect on transcrip-
tional activity of MMP-2 gene was increased with increasingBK CON 50 100 500 1000
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Fig. 5. Eﬀects of COS with diﬀerent molecular weights on the transcription
activity of MMP-2 was measured by luciferase assay in HDFs after cotransfec
mean ± S.E. of at least three independent experiments. Level of signiﬁcanceconcentrations of COS. In addition, all COS at 100 lg/ml
signiﬁcantly (P < 0.05) repressed transcriptional activity of
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al activity of MMP-2 promoter activation in HDFs. Transcriptional
tion with pMMP-2 reporter vector and pcDNA 3.1. Data represent the
was identiﬁed statistically (* indicates P < 0.01) using Student’s t test.
Fig. 6. Eﬀects of COS with diﬀerent molecular weights on gene
expression of MMP-2 and c-fos in HDFs. Cells were treated with
100 lg/ml of COS having diﬀerent molecular weights and gene
expression levels were determined by RT-PCR. Upper panel illustrates
PCR products of MMP-2, c-fos and G3PDH genes after electropho-
resis on 2% agarose gel. Lower panel represents densiometrically
determined respective relative gene expression levels normalized to
G3PDH. Values were expressed as relative gene expression using the
following equation. Relative gene expression (%) = (intensity of a
band/total intensity of bands) · 100. Data represent the means ± S.E.
of at least three independent experiments. Level of signiﬁcance was
identiﬁed statistically (* indicates P < 0.01) using Student’s t test.
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expression of MMP-2 and c-fos in HDFs
To conﬁrm the inhibitory eﬀect on gene expression of MMP-
2, we performed RT-PCR analysis using total cellular RNA
prepared from HDFs treated with diﬀerent molecular weights
of COS. As shown in Fig. 6, the gene expression of MMP-2
was completely inhibited by COS with 3–5 kDa. There was
no signiﬁcant diﬀerence in MMP-2 gene expression among
other groups. Further, MMP-2 gene expression is known to
be regulated via AP-1 transcription factor that binds to pro-
moter of all MMPs. Therefore, we investigated whether COSs
exert any inhibitory eﬀect on AP-1. For that, we tested the
gene expression of c-fos, a part of AP-1 transcription factor
in the presence of COS. All COS above 1 kDa exhibited inhib-
itory eﬀects on c-fos gene expression. Moreover, the highest
inhibitory eﬀect was observed with 3–5 kDa of COS.4. Discussion
Recently, much attention has been given to the use of chito-
san as a wound healing agent, antimicrobial agent, skin graft-ing template and drug delivery vehicle. However, these
biological activities remain unclear in human. In this study,
the inhibitory eﬀect of COS with diﬀerent molecular weights
on the expression and activation of MMP-2 was evaluated in
HDFs. COS with diﬀerent molecular weights did not exert
any cytotoxic eﬀect on normal human cells, and this was sup-
ported by the fact that COS have long been utilized as func-
tional foods in Korea. The broad speciﬁcity of MMP-2 may
play a role in the regulation of various cellular activities.
MMP-2 (gelatinase A, 72 kDa type IV collagenase) is a se-
creted endopeptidase able to hydrolyze several components
of the extracellular matrix including basement membrane col-
lagen IV and has been associated with tumor invasion and
metastasis [12,13].
To examine whether COS inhibit MMP-2 expression and
activation in HDFs, gelatin zymography was carried out.
We observed that PMA treatment could stimulate MMP-2
expression and activation in HDFs. Moreover, this observa-
tion was consistent with previous report that MMP-2 is se-
creted in a latent form that is activated by a sequential
cleavage of the N-terminal propeptide domain [14]. In this
study, for the ﬁrst time we found that COS with diﬀerent
molecular weights could inhibit activation of proMMP-2.
Chitosan has been known to have an eﬀective binding
capacity for Zn2+ and used in commercial chelating ion-ex-
change resins [15]. Therefore, it is possible that this inhibi-
tory eﬀect is due to the chelating ability of COS on Zn2+
that is vital for the activity of MMP-2. We further investi-
gated whether COS can inhibit MMP-2 protein expression
in HDFs. Western blot analysis using proMMP-2 monoclo-
nal antibody clearly conﬁrmed that COS can inhibit protein
expression of proMMP-2 in HDFs. Furthermore, COS with
3–5 kDa exhibited the highest inhibitory eﬀect on protein
expression of proMMP-2 and that was consistent with the
results of gelatin zymography analysis over time. Previous
research has shown that carbohydrates such as fucose-rich
polysaccharide can be an eﬃcient inhibitor capable of
down-regulating the expression and activity of MMP-2 with
potential therapeutic applications in age-related pathologies
accompanied by tissue loss [16]. Based on the results of
our experiment, we conﬁrmed that MMP-2 expression and
activation could be inhibited by COS in HDFs. Transcrip-
tional regulation has an important role in the synthesis of
MMP-2. Therefore, to investigate whether COS could aﬀect
transcriptional activity of MMP-2 in HDFs, reporter gene
assay using pMMP-2-luciferase construct was carried out.
It was observed that COS with 3–5 kDa could repress the
transcriptional activity of MMP-2 in HDFs, which was con-
sistent with the results of RT-PCR analysis. This observa-
tion can be further conﬁrmed by the ﬁnding that gene
expression level of c-fos was decreased by COS with 3–
5 kDa. The promoter of MMP-2 gene is notable for the ab-
sence of the conserved proximal AP-1 site, and MMP-2 in
contrast with most members of the MMP gene family is
not regulated by AP-1 [17]. However, previous report has
shown that there was a correlation between c-fos and
MMP-2 gene expression [18] and presence of AP-1 binding
site in promoter of MMP-2 [19]. It has also reported that
c-fos gene may play an important role in the regulation of
MMP-2 gene expression through activation of MT1-MMP
[20]. In conclusion, our ﬁndings provide the ﬁrst experimen-
2666 M.-M. Kim, S.-K. Kim / FEBS Letters 580 (2006) 2661–2666tal evidence that COS inhibit activation and expression of
MMP-2 in HDFs. These results suggest that COS may play
an important role in the prevention and treatment of MMP-
2 mediated several health problems such as metastasis and
wrinkle formation.
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